Exceeds threshold for national and global equality index markers by Bloomberg and the Human Rights Campaign FoundationDRAPER, Utah, Feb. 08, 2022…
BOCA RATON, Florida., Feb. 08, 2022 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused…
Toronto-based medical eyewear company partnered with visual assistance community to help empower Oregonian college student with enhanced visionTORONTO, Feb. 08,…
Healthcare providers rate Imprivata as #1 identity and access management provider citing ease of use for fast, secure, No Click…
Grant will support research to promote healthy living and aging THE ARTHUR M. BLANK FAMILY FOUNDATION GRANTS $15 MILLION TO…
OAKLAND, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- The Integrated Healthcare Association (IHA) announced today that Anna Lee Amarnath, MD,…
Sykes and Yzerman to Lead Innovation and Services Departments Atlanta, Georgia, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Avelead, a Streamline…
WORCESTER, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on…
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company developing…
INT301 Met Safety Goals Across Four Dose Levels in Cohort 1 Patient Treatment Now Ongoing in Fully Enrolled Cohort 2…